[{"address1": "7800 Susquehanna St.", "address2": "Suite 505", "city": "Pittsburgh", "state": "PA", "zip": "15208", "country": "United States", "phone": "412-901-0315", "website": "https://www.lipella.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Lipella Pharmaceuticals Inc., a biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. The company develops LP-10, a formulation of tacrolimus that has completed Phase 2a clinical trial for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; and LP-410, an oral liposomal formulation of tacrolimus for the treatment of oral graft-versus-host disease (GVHD). Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jonathan  Kaufman M.B.A., Ph.D.", "age": 57, "title": "Co-Founder, Chairman, CEO, President, Secretary & Treasurer", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 204133, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael B. Chancellor M.D.", "age": 65, "title": "Co-Founder, Chief Medical Officer & Director", "yearBorn": 1958, "fiscalYear": 2023, "totalPay": 195833, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Douglas  Johnston CPA", "age": 38, "title": "Chief Financial Officer", "yearBorn": 1985, "fiscalYear": 2023, "totalPay": 185000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Michele  Gruber", "title": "Director of Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Katie  Johnston", "title": "Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.387, "open": 0.39, "dayLow": 0.38, "dayHigh": 0.399, "regularMarketPreviousClose": 0.387, "regularMarketOpen": 0.39, "regularMarketDayLow": 0.38, "regularMarketDayHigh": 0.399, "forwardPE": -0.973, "volume": 106040, "regularMarketVolume": 106040, "averageVolume": 1099460, "averageVolume10days": 350840, "averageDailyVolume10Day": 350840, "bid": 0.3877, "ask": 0.399, "bidSize": 100, "askSize": 100, "marketCap": 3764202, "fiftyTwoWeekLow": 0.323, "fiftyTwoWeekHigh": 1.5, "priceToSalesTrailing12Months": 7.4214754, "fiftyDayAverage": 0.43138, "twoHundredDayAverage": 0.642285, "currency": "USD", "enterpriseValue": 2022577, "floatShares": 5206215, "sharesOutstanding": 9671640, "sharesShort": 174738, "sharesShortPriorMonth": 120542, "sharesShortPreviousMonthDate": 1726185600, "dateShortInterest": 1728950400, "sharesPercentSharesOut": 0.0216, "heldPercentInsiders": 0.35492, "heldPercentInstitutions": 0.07874, "shortRatio": 0.08, "shortPercentOfFloat": 0.032899998, "bookValue": 0.224, "priceToBook": 1.7375, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -4142409, "trailingEps": -0.61, "forwardEps": -0.4, "enterpriseToRevenue": 3.988, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "LIPO", "underlyingSymbol": "LIPO", "shortName": "Lipella Pharmaceuticals Inc.", "longName": "Lipella Pharmaceuticals Inc.", "firstTradeDateEpochUtc": 1671460200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "d39a1b66-6fea-3b6c-8773-cda09b9e9d93", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.3892, "targetHighPrice": 2.0, "targetLowPrice": 2.0, "targetMeanPrice": 2.0, "targetMedianPrice": 2.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 1186506, "totalCashPerShare": 0.148, "totalDebt": 93679, "quickRatio": 2.544, "currentRatio": 4.332, "totalRevenue": 507204, "debtToEquity": 5.498, "revenuePerShare": 0.074, "returnOnAssets": -0.9377, "returnOnEquity": -1.71559, "freeCashflow": -2254496, "operatingCashflow": -3724304, "revenueGrowth": 0.279, "operatingMargins": -6.97927, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-11-04"}]